Literature DB >> 19735078

Mechanism of cell death by 5-aminolevulinic acid-based photodynamic action and its enhancement by ferrochelatase inhibitors in human histiocytic lymphoma cell line U937.

Takashi Amo1, Noriaki Kawanishi, Masataka Uchida, Hirofumi Fujita, Eri Oyanagi, Toshihiko Utsumi, Tetsuya Ogino, Keiji Inoue, Taro Shuin, Kozo Utsumi, Junzo Sasaki.   

Abstract

Photodynamic therapy (PDT) for tumors is based on the tumor-selective accumulation of a photosensitizer, protoporphyrin IX (PpIX), followed by irradiation with visible light. However, the molecular mechanism of cell death caused by PDT has not been fully elucidated. The 5-aminolevulinic acid (ALA)-based photodynamic action (PDA) was dependent on the accumulation of PpIX, the level of which decreased rapidly by eliminating ALA from the incubation medium in human histiocytic lymphoma U937 cells. PDA induced apoptosis characterized by lipid peroxidation, increase in Bak and Bax/Bcl-xL, decrease in Bid, membrane depolarization, cytochrome c release, caspase-3 activation, phosphatidylserine (PS) externalization. PDT-induced cell death seemed to occur predominantly via apoptosis through distribution of PpIX in mitochondria. These cell death events were enhanced by ferrochelatase inhibitors. These results indicated that ALA-based-PDA induced apoptotic cell death through a mitochondrial pathway and that ferrochelatase inhibitors might enhanced the effect of PDT for tumors even at low concentrations of ALA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19735078     DOI: 10.1002/cbf.1603

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  15 in total

1.  Metformin enhances the cytotoxicity of 5-aminolevulinic acid-mediated photodynamic therapy in vitro.

Authors:  Tomohiro Osaki; Inoru Yokoe; Kiwamu Takahashi; Katsushi Inoue; Masahiro Ishizuka; Tohru Tanaka; Kazuo Azuma; Yusuke Murahata; Takeshi Tsuka; Norihiko Itoh; Tomohiro Imagawa; Yoshiharu Okamoto
Journal:  Oncol Lett       Date:  2017-05-24       Impact factor: 2.967

2.  Serum-dependent export of protoporphyrin IX by ATP-binding cassette transporter G2 in T24 cells.

Authors:  Tetsuya Ogino; Hirotsugu Kobuchi; Kazuaki Munetomo; Hirofumi Fujita; Masanao Yamamoto; Toshihiko Utsumi; Keiji Inoue; Taro Shuin; Junzo Sasaki; Masayasu Inoue; Kozo Utsumi
Journal:  Mol Cell Biochem       Date:  2011-07-12       Impact factor: 3.396

3.  Multifunctional 5-aminolevulinic acid prodrugs activating diverse cell-death pathways.

Authors:  Gili Berkovitch-Luria; Michal Weitman; Abraham Nudelman; Ada Rephaeli; Zvi Malik
Journal:  Invest New Drugs       Date:  2011-04-21       Impact factor: 3.850

4.  Small-molecule inhibitors of ferrochelatase are antiangiogenic agents.

Authors:  Kamakshi Sishtla; Nathan Lambert-Cheatham; Bit Lee; Duk Hee Han; Jaehui Park; Sheik Pran Babu Sardar Pasha; Sanha Lee; Sangil Kwon; Anbukkarasi Muniyandi; Bomina Park; Noa Odell; Sydney Waller; Il Yeong Park; Soo Jae Lee; Seung-Yong Seo; Timothy W Corson
Journal:  Cell Chem Biol       Date:  2022-01-31       Impact factor: 9.039

Review 5.  Biomodulatory approaches to photodynamic therapy for solid tumors.

Authors:  Sanjay Anand; Bernhard J Ortel; Stephen P Pereira; Tayyaba Hasan; Edward V Maytin
Journal:  Cancer Lett       Date:  2012-07-25       Impact factor: 8.679

Review 6.  Protoporphyrin IX: the Good, the Bad, and the Ugly.

Authors:  Madhav Sachar; Karl E Anderson; Xiaochao Ma
Journal:  J Pharmacol Exp Ther       Date:  2015-11-20       Impact factor: 4.030

7.  Efficacy of 5-aminolevulinic acid-mediated photodynamic therapy using light-emitting diodes in human colon cancer cells.

Authors:  Tomoya Hatakeyama; Yasutoshi Murayama; Shuhei Komatsu; Atsushi Shiozaki; Yoshiaki Kuriu; Hisashi Ikoma; Masayoshi Nakanishi; Daisuke Ichikawa; Hitoshi Fujiwara; Kazuma Okamoto; Toshiya Ochiai; Yukihito Kokuba; Katsushi Inoue; Motowo Nakajima; Eigo Otsuji
Journal:  Oncol Rep       Date:  2013-01-03       Impact factor: 3.906

8.  Effect of 5-aminolevulinic acid-based photodynamic therapy via reactive oxygen species in human cholangiocarcinoma cells.

Authors:  Cy Hyun Kim; Chung-Wook Chung; Kyung Ha Choi; Jin-Ju Yoo; Do Hyung Kim; Young-Il Jeong; Dae Hwan Kang
Journal:  Int J Nanomedicine       Date:  2011-06-30

9.  In vitro comparison of hypericin and 5-aminolevulinic acid-derived protoporphyrin IX for photodynamic inactivation of medulloblastoma cells.

Authors:  Rainer Ritz; Christian Scheidle; Susan Noell; Florian Roser; Martin Schenk; Klaus Dietz; Wolfgang S L Strauss
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

10.  Mitochondrial localization of ABC transporter ABCG2 and its function in 5-aminolevulinic acid-mediated protoporphyrin IX accumulation.

Authors:  Hirotsugu Kobuchi; Koko Moriya; Tetsuya Ogino; Hirofumi Fujita; Keiji Inoue; Taro Shuin; Tatsuji Yasuda; Kozo Utsumi; Toshihiko Utsumi
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.